Publications

BibTex format

@article{Thomas:2017:10.1016/S2214-109X(17)30367-4,
author = {Thomas, RA and Burger, R and Harper, A and Kanema, S and Mwenge, L and Vanqa, N and Bell-Mandla, N and Smith, P and Floyd, S and Bock, P and Ayles, H and Beyers, N and Donnell, D and Fidler, S and Hayes, R and Hauck, K},
doi = {10.1016/S2214-109X(17)30367-4},
journal = {The Lancet Global Health},
pages = {e1133--e1141},
title = {Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial},
url = {http://dx.doi.org/10.1016/S2214-109X(17)30367-4},
volume = {5},
year = {2017}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BackgroundThe life expectancy of HIV-positive individuals receiving antiretroviral therapy (ART) is approaching that of HIV-negative people. However, little is known about how these populations compare in terms of health-related quality of life (HRQoL). We aimed to compare HRQoL between HIV-positive and HIV-negative people in Zambia and South Africa.MethodsAs part of the HPTN 071 (PopART) study, data from adults aged 18–44 years were gathered between Nov 28, 2013, and March 31, 2015, in large cross-sectional surveys of random samples of the general population in 21 communities in Zambia and South Africa. HRQoL data were collected with a standardised generic measure of health across five domains. We used β-distributed multivariable models to analyse differences in HRQoL scores between HIV-negative and HIV-positive individuals who were unaware of their status; aware, but not in HIV care; in HIV care, but who had not initiated ART; on ART for less than 5 years; and on ART for 5 years or more. We included controls for sociodemographic variables, herpes simplex virus type-2 status, and recreational drug use.FindingsWe obtained data for 19750 respondents in Zambia and 18941 respondents in South Africa. Laboratory-confirmed HIV status was available for 19330 respondents in Zambia and 18004 respondents in South Africa; 4128 (21%) of these 19330 respondents in Zambia and 4012 (22%) of 18004 respondents in South Africa had laboratory-confirmed HIV. We obtained complete HRQoL information for 19637 respondents in Zambia and 18429 respondents in South Africa. HRQoL scores did not differ significantly between individuals who had initiated ART more than 5 years previously and HIV-negative individuals, neither in Zambia (change in mean score −0·002, 95% CI −0·01 to 0·001; p=0·219) nor in South Africa (0·000, −0·002 to 0·003; p=0·939). However, scores did differ between HIV-positive individu
AU  - Thomas,RA
AU  - Burger,R
AU  - Harper,A
AU  - Kanema,S
AU  - Mwenge,L
AU  - Vanqa,N
AU  - Bell-Mandla,N
AU  - Smith,P
AU  - Floyd,S
AU  - Bock,P
AU  - Ayles,H
AU  - Beyers,N
AU  - Donnell,D
AU  - Fidler,S
AU  - Hayes,R
AU  - Hauck,K
DO  - 10.1016/S2214-109X(17)30367-4
EP  - 1141
PY  - 2017///
SN  - 2214-109X
SP  - 1133
TI  - Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial
T2  - The Lancet Global Health
UR  - http://dx.doi.org/10.1016/S2214-109X(17)30367-4
UR  - http://hdl.handle.net/10044/1/51442
VL  - 5
ER  -

Download

DrAnneCori

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)